Product Name :
HS-27
Description:
HS-27, a fluorescently-tethered Hsp90 inhibitor, assays surface Hsp90 expression on intact tissue specimens. HS-27 is made up of the core elements of SNX-5422, an Hsp90 inhibitor, tethered via a PEG linker to a fluorescein derivative (fluorescein isothiocyanate or FITC), that binds to ectopically expressed Hsp90. HS-27 has potential use in a see-and-treat paradigm in breast cancer.
CAS:
1562024-11-6
Molecular Weight:
993.13
Formula:
C52H60N6O12S
Chemical Name:
2-{20-[({3′,6′-dihydroxy-3-oxo-3H-spiro[2-benzofuran-1,9′-xanthen]-5-yl}carbamothioyl)amino]-5,8,11,14,17-pentaoxa-1-azaicosan-1-yl}-4-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-indazol-1-yl)benzamide
Smiles :
CC1(C)CC(=O)C2=C(C1)N(N=C2C)C1=CC(NCCCOCCOCCOCCOCCOCCCNC(=S)NC2=CC3=C(C=C2)C2(OC3=O)C3=CC=C(O)C=C3OC3=CC(O)=CC=C23)=C(C=C1)C(N)=O
InChiKey:
QUGHMMYGFASWKI-UHFFFAOYSA-N
InChi :
InChI=1S/C52H60N6O12S/c1-32-47-43(30-51(2,3)31-44(47)61)58(57-32)34-7-10-37(48(53)62)42(27-34)54-14-4-16-64-18-20-66-22-24-68-25-23-67-21-19-65-17-5-15-55-50(71)56-33-6-11-39-38(26-33)49(63)70-52(39)40-12-8-35(59)28-45(40)69-46-29-36(60)9-13-41(46)52/h6-13,26-29,54,59-60H,4-5,14-25,30-31H2,1-3H3,(H2,53,62)(H2,55,56,71)
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.{{NNZ 2591} medchemexpress|{NNZ 2591} Protocol|{NNZ 2591} Data Sheet|{NNZ 2591} manufacturer|{NNZ 2591} Autophagy}
Shelf Life:
≥12 months if stored properly.
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
HS-27, a fluorescently-tethered Hsp90 inhibitor, assays surface Hsp90 expression on intact tissue specimens. HS-27 is made up of the core elements of SNX-5422, an Hsp90 inhibitor, tethered via a PEG linker to a fluorescein derivative (fluorescein isothiocyanate or FITC), that binds to ectopically expressed Hsp90. HS-27 has potential use in a see-and-treat paradigm in breast cancer.|Product information|CAS Number: 1562024-11-6|Molecular Weight: 993.13|Formula: C52H60N6O12S|Chemical Name: 2-{20-[({3′,6′-dihydroxy-3-oxo-3H-spiro[2-benzofuran-1,9′-xanthen]-5-yl}carbamothioyl)amino]-5,8,11,14,17-pentaoxa-1-azaicosan-1-yl}-4-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-indazol-1-yl)benzamide|Smiles: CC1(C)CC(=O)C2=C(C1)N(N=C2C)C1=CC(NCCCOCCOCCOCCOCCOCCCNC(=S)NC2=CC3=C(C=C2)C2(OC3=O)C3=CC=C(O)C=C3OC3=CC(O)=CC=C23)=C(C=C1)C(N)=O|InChiKey: QUGHMMYGFASWKI-UHFFFAOYSA-N|InChi: InChI=1S/C52H60N6O12S/c1-32-47-43(30-51(2,3)31-44(47)61)58(57-32)34-7-10-37(48(53)62)42(27-34)54-14-4-16-64-18-20-66-22-24-68-25-23-67-21-19-65-17-5-15-55-50(71)56-33-6-11-39-38(26-33)49(63)70-52(39)40-12-8-35(59)28-45(40)69-46-29-36(60)9-13-41(46)52/h6-13,26-29,54,59-60H,4-5,14-25,30-31H2,1-3H3,(H2,53,62)(H2,55,56,71)|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Solubility: DMSO : 125 mg/mL (125.{{Vilobelimab} medchemexpress|{Vilobelimab} Immunology/Inflammation|{Vilobelimab} Biological Activity|{Vilobelimab} Description|{Vilobelimab} supplier|{Vilobelimab} Autophagy} 86 mM; Need ultrasonic).PMID:24275718 |Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.|Shelf Life: ≥12 months if stored properly.|Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.|Drug Formulation: To be determined|HS Tariff Code: 382200|How to use|In Vitro:|HS-27 labels all receptor subtypes of breast cancer, but not normal cells, and specifically binds to Hsp90 expressed on the surface of breast cancer cells before being internalized. HS-27 fluorescence is greater in tumor than non-tumor tissue.|Products are for research use only. Not for human use.|
